These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24890721)

  • 1. Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody response.
    Hu J; Oda SK; Shotts K; Donovan EE; Strauch P; Pujanauski LM; Victorino F; Al-Shami A; Fujiwara Y; Tigyi G; Oravecz T; Pelanda R; Torres RM
    J Immunol; 2014 Jul; 193(1):85-95. PubMed ID: 24890721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPA
    Mathew D; Kremer KN; Strauch P; Tigyi G; Pelanda R; Torres RM
    Front Immunol; 2019; 10():1159. PubMed ID: 31231367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial signaling through TLR-2 and CD86 augments activation and differentiation of resting B cells.
    Jain S; Chodisetti SB; Agrewala JN
    PLoS One; 2013; 8(1):e54392. PubMed ID: 23365665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct signal thresholds for the unique antigen receptor-linked gene expression programs in mature and immature B cells.
    Benschop RJ; Melamed D; Nemazee D; Cambier JC
    J Exp Med; 1999 Sep; 190(6):749-56. PubMed ID: 10499913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.
    Oda SK; Strauch P; Fujiwara Y; Al-Shami A; Oravecz T; Tigyi G; Pelanda R; Torres RM
    Cancer Immunol Res; 2013 Oct; 1(4):245-55. PubMed ID: 24455753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5.
    Lee CW; Rivera R; Gardell S; Dubin AE; Chun J
    J Biol Chem; 2006 Aug; 281(33):23589-97. PubMed ID: 16774927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain.
    Lin ME; Rivera RR; Chun J
    J Biol Chem; 2012 May; 287(21):17608-17617. PubMed ID: 22461625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation.
    Lee CW; Rivera R; Dubin AE; Chun J
    J Biol Chem; 2007 Feb; 282(7):4310-4317. PubMed ID: 17166850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPA5 is abundantly expressed by human mast cells and important for lysophosphatidic acid induced MIP-1β release.
    Lundequist A; Boyce JA
    PLoS One; 2011 Mar; 6(3):e18192. PubMed ID: 21464938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 7 controls the anti-retroviral germinal center response.
    Browne EP
    PLoS Pathog; 2011 Oct; 7(10):e1002293. PubMed ID: 21998589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
    Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
    Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of LncRNA 2900052N01Rik inhibits LPS-induced B cell function in vitro.
    Wang F; Luo Y; Zhang L; Younis M; Yuan L
    Cell Immunol; 2021 May; 363():104321. PubMed ID: 33773377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD22 is a negative regulator of B-cell receptor signalling.
    Nitschke L; Carsetti R; Ocker B; Köhler G; Lamers MC
    Curr Biol; 1997 Feb; 7(2):133-43. PubMed ID: 9016707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
    Lee Y; Haas KM; Gor DO; Ding X; Karp DR; Greenspan NS; Poe JC; Tedder TF
    J Immunol; 2005 Dec; 175(12):8011-23. PubMed ID: 16339538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of CD8 T-cell signaling, metabolism, and cytotoxic activity by extracellular lysophosphatidic acid.
    Torres RM; Turner JA; D'Antonio M; Pelanda R; Kremer KN
    Immunol Rev; 2023 Aug; 317(1):203-222. PubMed ID: 37096808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines.
    Nadler MJ; McLean PA; Neel BG; Wortis HH
    J Immunol; 1997 Nov; 159(9):4233-43. PubMed ID: 9379018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of lysophosphatidic acid receptor 5 is necessary for the regulation of intestinal Na
    Jenkin KA; He P; Yun CC
    Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G433-G442. PubMed ID: 29792531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmodulation of BCR signaling by transduction-incompetent antigen receptors: implications for impaired signaling in anergic B cells.
    Vilen BJ; Burke KM; Sleater M; Cambier JC
    J Immunol; 2002 May; 168(9):4344-51. PubMed ID: 11970976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogenic signaling by lysophosphatidic acid (LPA) involves Galpha12.
    Radhika V; Hee Ha J; Jayaraman M; Tsim ST; Dhanasekaran N
    Oncogene; 2005 Jun; 24(28):4597-603. PubMed ID: 15856019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
    Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T
    Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.